An international, biomarker-directed, randomized, phase II trial of AZD1775 plus paclitaxel and carboplatin (P/C) for the treatment of women with platinum-sensitive, TP53-mutant ovarian cancer.
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | OZA, Amit M. | |
dc.contributor.author | WEBERPALS, Johanne Ingrid | |
dc.contributor.author | PROVENCHER, Diane M. | |
dc.contributor.author | GRISCHKE, Eva-Maria | |
dc.contributor.author | HALL, Marcia | |
dc.contributor.author | UYAR, Denise | |
dc.contributor.author | ESTEVEZ-DIZ, Maria Del Pilar | |
dc.contributor.author | MARME, Frederik | |
dc.contributor.author | KUZMIN, Alexey | |
dc.contributor.author | ROSENBERG, Per | |
dc.contributor.author | WENHAM, Robert Michael | |
dc.contributor.author | QIU, Jingjun | |
dc.contributor.author | LEE, Mark Anthony | |
dc.contributor.author | LIU, Ji | |
dc.contributor.author | ROSE, Shelonitda | |
dc.contributor.author | MOORE, Kathleen N. | |
dc.date.accessioned | 2015-11-11T16:36:09Z | |
dc.date.available | 2015-11-11T16:36:09Z | |
dc.date.issued | 2015 | |
dc.description.conferencedate | MAY 29-JUN 02, 2015 | |
dc.description.conferencelocal | Chicago, IL | |
dc.description.conferencename | Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) | |
dc.description.index | MEDLINE | |
dc.identifier.citation | JOURNAL OF CLINICAL ONCOLOGY, v.33, n.15, suppl.S, 2015 | |
dc.identifier.eissn | 1527-7755 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/12231 | |
dc.language.iso | eng | |
dc.publisher | AMER SOC CLINICAL ONCOLOGY | |
dc.relation.ispartof | Journal of Clinical Oncology | |
dc.rights | restrictedAccess | |
dc.rights.holder | Copyright AMER SOC CLINICAL ONCOLOGY | |
dc.subject.wos | Oncology | |
dc.title | An international, biomarker-directed, randomized, phase II trial of AZD1775 plus paclitaxel and carboplatin (P/C) for the treatment of women with platinum-sensitive, TP53-mutant ovarian cancer. | |
dc.type | conferenceObject | |
dc.type.category | meeting abstract | |
dc.type.version | publishedVersion | |
dspace.entity.type | Publication | |
hcfmusp.contributor.author-fmusphc | MARIA DEL PILAR ESTEVEZ DIZ | |
hcfmusp.description.issue | 15 | |
hcfmusp.description.issue | suppl S | |
hcfmusp.description.volume | 33 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.wos | WOS:000358036901164 | |
hcfmusp.publisher.city | ALEXANDRIA | |
hcfmusp.publisher.country | USA | |
relation.isAuthorOfPublication | 133ef298-fd48-49b5-8d0f-fd469d382078 | |
relation.isAuthorOfPublication.latestForDiscovery | 133ef298-fd48-49b5-8d0f-fd469d382078 |